Ingevity (NGVT) | Stock Overview & Key Data
Ingevity Performance Comparison
Stock Range
Today's Range
Low: $49.94
High: $52.05
on August 8, 2025
52 Week Range
Low: $28.49
High: $52.05
on April 9, 2025
on August 8, 2025
All-Time High: $120.41 on February 18, 2019
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.7B
EPS
-9.75
P/E Ratio (TTM)
12.96
Forward P/E
11.82
P/B Ratio
14.48
PEG Ratio
11.82
Div. Yield
N/A
ROE
-106.83%
Beta
N/A
Debt to Equity
1,102.15
Financial Highlights
Profitability
Gross Margin
39.93%
Operating Margin
23.53%
Profit Margin
-16.35%
Returns and Earnings
Return on Assets (TTM)
8.86%
Return on Equity (TTM)
-106.83%
EBITDA
$363.9M
Net Income (TTM)
$-216.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$36.45
Quarterly Revenue Growth (YoY)
-6.50%
Quarterly Earnings Growth (YoY)
-16.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Ingevity NGVT | 1.75B Small-cap | 26.91% | 9.57% | 27.25% | 15.58% | 29.67% | 43.98% | -31.74% | -15.58% |
| Linde plc LIN | 222.60B Mega-cap | 2.83% | 0.53% | 4.23% | 2.51% | 14.06% | 5.68% | 51.64% | 90.11% |
| Sherwin-Williams SHW | 86.26B Large-cap | 2.55% | 1.78% | -0.40% | -1.95% | 5.70% | 1.91% | 39.99% | 58.53% |
| Innospec IOSP | 1.99B Small-cap | 3.68% | -8.27% | -12.81% | -26.62% | -24.34% | -23.47% | -18.11% | 3.64% |
| Chemours CC | 1.80B Small-cap | 6.00% | -10.56% | 8.45% | -32.16% | -27.05% | -32.67% | -66.72% | -41.82% |
| Minerals MTX | 1.77B Small-cap | 2.66% | -0.99% | 5.04% | -19.94% | -22.67% | -17.68% | -11.30% | 8.72% |
Ownership & Short Interest
Insider Ownership
1.21%
Institutional Ownership
103.41%
Shares Short
1M
Short Ratio
5.78
Short % of Shares Outstanding
4.66%
Average 10-Day Volume
225K
Average 90-Day Volume
216K
Ingevity Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Ingevity would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NGVT's 52-week high and low?
- In the last 52 weeks, Ingevity reached a high of $52.05 (on August 8, 2025) and a low of $28.49 (on April 9, 2025).
- What is the market cap and P/E ratio for NGVT?
- Curious about Ingevity's size and valuation? Its market capitalization stands at 1.75B. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.96, and the forward P/E (looking ahead) is 11.82.
- Does NGVT pay dividends? If so, what's the yield?
- As for dividends, Ingevity isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ingevity's main competitors or similar companies to consider before investing?
When looking at Ingevity, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Linde plc
LIN222.60B Basic Materials Specialty Chemicals 5.68% 51.64% Sherwin-Williams
SHW86.26B Basic Materials Specialty Chemicals 1.91% 39.99% Innospec
IOSP1.99B Basic Materials Specialty Chemicals -23.47% -18.11% Chemours
CC1.80B Basic Materials Specialty Chemicals -32.67% -66.72% Minerals
MTX1.77B Basic Materials Specialty Chemicals -17.68% -11.30% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ingevity Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Ingevity's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -106.83%, the Debt to Equity ratio from the most recent quarter is 1,102.15, and its Gross Profit Margin stands at 39.93%.
- What is the recent revenue and earnings growth for NGVT?
- Looking at Ingevity's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.50%, and quarterly earnings saw a YoY growth of -16.50%.
- How much of NGVT stock is held by insiders and institutions?
- Wondering who owns Ingevity stock? Company insiders (like executives and directors) hold about 1.21% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 103.41%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.